West Virginia Intellectual Property Cases
Cases 51 - 60 of 130
GILEAD SCIENCES, INC. et al v. Mylan Inc. et al
as 1:2015cv00149
Plaintiff:
GILEAD SCIENCES, INC. and EMORY UNIVERSITY
Defendant:
Mylan Inc. and Mylan Pharmaceuticals Inc.
Counter_claimant:
Mylan Inc. and Mylan Pharmaceuticals Inc.
Counter_defendant:
EMORY UNIVERSITY and GILEAD SCIENCES, INC.
Cause Of Action: 28 U.S.C. § 1338
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2015cv00145
Plaintiff:
Boehringer Ingelheim Pharmaceuticals, Inc. , Boehringer Ingelheim International GmbH , Boehringer Ingelheim Corporation and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Janssen Biotech, Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2015cv00130
Plaintiff:
Janssen Biotech, Inc. , Janssen Oncology, Inc. and Janssen Research & Development, LLC
Defendant:
Mylan Pharmaceuticals Inc. and Mylan, Inc.
Cause Of Action: 35 U.S.C. § 271
Salix Pharmaceuticals, Inc et al v. Mylan Pharmaceuticals, Inc. et al
as 1:2015cv00109
Plaintiff:
Salix Pharmaceuticals, Inc and Dr. Falk Pharma GmbH
Defendant:
Mylan Pharmaceuticals, Inc. and Mylan, Inc.
Counter_claimant:
Mylan, Inc. and Mylan Pharmaceuticals, Inc.
Counter_defendant:
Dr. Falk Pharma GmbH and Salix Pharmaceuticals, Inc
Cause Of Action: 35 U.S.C. § 271
Hawk Technology Systems, LLC v. Valley Health System
as 3:2015cv00077
Plaintiff:
Hawk Technology Systems, LLC
Defendant:
Valley Health System
Cause Of Action: 35 U.S.C. § 271
DUCHESNAY INC. et al v. MYLAN PHARMACEUTICALS INC.
as 1:2015cv00092
Plaintiff:
DUCHESNAY INC. and DUCHESNAY USA INC.
Defendant:
MYLAN PHARMACEUTICALS INC.
Counter_claimant:
MYLAN PHARMACEUTICALS INC.
Counter_defendant:
DUCHESNAY INC.
Cause Of Action: 35 U.S.C. § 271
Takeda GMBH et al v. Mylan Pharmaceuticals Inc.
as 1:2015cv00093
Plaintiff:
Takeda GMBH , Astrazeneca Pharmaceuticals LP and Astrazeneca UK Limited
Defendant:
Mylan Pharmaceuticals Inc.
Counter_claimant:
Mylan Pharmaceuticals Inc.
Counter_defendant:
Astrazeneca Pharmaceuticals LP , Astrazeneca UK Limited and Takeda GMBH
Cause Of Action: 35 U.S.C. § 271
Vanda Pharmaceuticals Inc. v. Inventia Healthcare Pvt. Ltd.
as 3:2015cv00059
Plaintiff:
Vanda Pharmaceuticals Inc.
Defendant:
Inventia Healthcare Pvt. Ltd.
Counter_claimant:
Inventia Healthcare Pvt. Ltd.
Counter_defendant:
Vanda Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 145
Noven Pharmaceuticals, Inc. et al v. Mylan Technologies, Inc. et al
as 1:2015cv00069
Plaintiff:
Noven Pharmaceuticals, Inc. and Hisamitsu Pharmaceutical Co., Inc.
Defendant:
Mylan Technologies, Inc. , Mylan Pharmaceuticals, Inc. and Mylan Inc.
Counter_claimant:
Mylan Technologies, Inc. , Mylan Pharmaceuticals, Inc. and Mylan Inc.
Counter_defendant:
Hisamitsu Pharmaceutical Co., Inc. and Noven Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Bristol-Myers Squibb Company v. Mylan Pharmaceuticals, Inc.
as 1:2015cv00049
Plaintiff:
Bristol-Myers Squibb Company
Defendant:
Mylan Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
